Stay updated on Pembrolizumab vs Platinum-based Chemo in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Platinum-based Chemo in Urothelial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Platinum-based Chemo in Urothelial Carcinoma Clinical Trial page
- Check4 days agoChange DetectedThe footer shows Revision: v3.6.4 now, replacing the previous v3.6.3. This is a minor version update and does not change study content or how the page operates.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe revision history now shows v3.6.3 as the latest revision, replacing v3.6.2.SummaryDifference0.1%

- Check32 days agoChange DetectedRevision: v3.6.2 appears in the page footer, replacing v3.6.0, indicating a newer build of the Record History page.SummaryDifference0.1%

- Check46 days agoChange DetectedA new note indicates recruitment is closed, updating the study's participation status. The history also shows a new revision tag (v3.6.0) and the removal of a previous revision (v3.5.5).SummaryDifference0.2%

- Check53 days agoChange DetectedThe footer revision label was updated from v3.5.4 to v3.5.5, indicating a new build of the ClinicalTrials.gov history page; no changes to the study records themselves.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4 in the page footer, representing an updated version of the record history display.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs Platinum-based Chemo in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Platinum-based Chemo in Urothelial Carcinoma Clinical Trial page.